Showing results (1431-1440 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|December 17, 2004
Levodopa infusion therapy in Parkinson disease: state of the art in 2004Dag Nyholm, Sten-Magnus AquiloniusClinical Neuropharmacology|December 23, 2004
IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effectsPatrizia Pellegrini, Rocco Totaro, Ida Contasta, et al.Clinical Neuropharmacology|December 23, 2004
The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson diseaseHiroshi Nagayama, Makoto Hamamoto, Masayuki Ueda, et al.Clinical Neuropharmacology|December 23, 2004
Open-label zonisamide for refractory migraineMiles E Drake, Nancy I Greathouse, Janet B Renner, et al.Clinical Neuropharmacology|February 16, 2005
Case studies of adjunctive agents in clozapine-resistant schizophrenic patientsVassilis P Kontaxakis, Panayotis P Ferentinos, Beata J Havaki-Kontaxaki, et al.Clinical Neuropharmacology|March 7, 2006
Irreversible neurological worsening following high-dose corticosteroids in advanced progressive multiple sclerosisMarcus Koch, Jacques De KeyserClinical Neuropharmacology|March 7, 2006
Current therapeutic options in severe Guillain-Barré syndromeEli ShaharClinical Neuropharmacology|December 1, 1991
Serotonin reuptake inhibitors, paranoia, and the ventral basal gangliaE C LauterbachClinical Neuropharmacology|April 3, 2008
Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasmsLi-Ping Zou, Qing Lin, Jiong Qin, et al.Clinical Neuropharmacology|February 20, 2002
Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's diseaseHüseyin A Sahin, I Hakan Gurvit, Başar Bilgiç, et al.Pageof 237